Patent · US Active

Method of transdermal drug delivery

US8467868B1 · kind B1 · utility

0Cited by
2References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 26, 2006
Grant dateJun 18, 2013
Priority date
Expiry dateDec 25, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N1/325
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A method of transdermal drug delivery using drug formulations and other small molecules is described. The drug or other small molecule formulation is applied to the skin of a patient using a radio frequency device. The radio frequency device facilitates the ablation of the stratum corneum allowing the drug or other small molecule to pass to the underlying skin. The drug or small molecule can be contained in hyaluronic acid nanoparticles or suspended in a gel.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.